Brand drug makers are warning against relying on 340B hospitals to execute Louisiana’s plan to pay a subscription for an unlimited supply of hepatitis C drugs over a fixed period. Pew, which came up with the idea as a way to avoid the Medicaid best price law, said routing the drugs through 340B hospitals would not expand the drug discount program, but the Pharmaceutical Research and Manufacturers of America disagrees. “While we agree that manufacturers can face challenges due to...